BLCO · Healthcare
BAUSCH PLUS LOMB CORP
Smart-money confidence
· 1 of 3 sources firing
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
32
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$5.8B
Industry
Medical Instruments & Supplies
Sector
Healthcare
Exchange
NYSE
About BAUSCH PLUS LOMB CORP
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products,…
Who's behind the signal
Every informed buyer we can see on BLCO, across all three feeds.
Hedge funds · 6
Point72 (Steve Cohen)
New position
Millennium Management (Englander)
New position
Glenview Capital Mgmt (Robbins)
Increased +6%
D.E. Shaw & Co
Increased +9%
Citadel Advisors
Increased +30%
Tudor Investment (Paul Tudor Jones)
Decreased −39%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar.
BAUSCH PLUS LOMB CORP isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
2
New positions
3
Increasing
1
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
NEW
0.0% of Millennium Management's portfolio
Trust weight: 1.2×
% of portfolio
0.6%
Position change
+6%
0.6% of Glenview Capital Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+9%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+30%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.2×
% of portfolio
0.0%
Position change
−39%
0.0% of Tudor Investment's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to BAUSCH PLUS LOMB CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell BAUSCH PLUS LOMB CORP or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime